Be a Smart Investor
Friday, January 5, 2018
Acorda Therapeutics reportedly exploring potential sale
Investors in August had called for the company to explore a sale, after a judge in March struck down key patents of its MS drug Ampyra.
from Mergers and Acquisitions http://ift.tt/2CKGlAy
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment